Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”

Detalles Bibliográficos
Autores principales: Abdelazeem, Basel, Abbas, Kirellos Said, Brašić, James Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228947/
https://www.ncbi.nlm.nih.gov/pubmed/35744055
http://dx.doi.org/10.3390/medicina58060793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228947/
https://www.ncbi.nlm.nih.gov/pubmed/35744055
http://dx.doi.org/10.3390/medicina58060793

Ejemplares similares